Fidji Simo's ChronicleBio uses AI to find treatments for chronic diseases

Fidji Simo's company ChronicleBio aims to develop treatments for POTS, Long COVID, ME/CFS, and hEDS, which currently have zero FDA-approved therapies. The company plans to build the deepest dataset on these conditions and use AI to identify the biology behind their symptoms. The goal is to match the right drugs to the right patients.